Quick Links
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
For the remainder of 2018, Astellas will not increase any of the company’s drug prices in the United States. Astellas believes that the price of medicines should be a fair reflection of the value they bring to patients, healthcare systems and society as a whole. Astellas looks forward to working with the Department of Health and Human Services (HHS) as the department implements its blueprint to reform the healthcare system and improve access for patients. Astellas remains committed to advancing constructive policies that foster medical innovation while ensuring patients’ access to medicines.
Follow U.S. news
